IL125479A0 - Aspartyl protease inhibitors pharmaceutical compositions containing the same and a process for their production - Google Patents
Aspartyl protease inhibitors pharmaceutical compositions containing the same and a process for their productionInfo
- Publication number
- IL125479A0 IL125479A0 IL12547997A IL12547997A IL125479A0 IL 125479 A0 IL125479 A0 IL 125479A0 IL 12547997 A IL12547997 A IL 12547997A IL 12547997 A IL12547997 A IL 12547997A IL 125479 A0 IL125479 A0 IL 125479A0
- Authority
- IL
- Israel
- Prior art keywords
- production
- same
- pharmaceutical compositions
- compositions containing
- protease inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
- C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/592,777 US5883252A (en) | 1996-01-26 | 1996-01-26 | Aspartyl protease inhibitors |
US08/724,563 US5945413A (en) | 1996-01-26 | 1996-09-30 | Aspartyl protease inhibitors |
PCT/US1997/001610 WO1997027180A1 (en) | 1996-01-26 | 1997-01-22 | Aspartyl protease inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
IL125479A0 true IL125479A0 (en) | 1999-03-12 |
Family
ID=27081545
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12547997A IL125479A0 (en) | 1996-01-26 | 1997-01-22 | Aspartyl protease inhibitors pharmaceutical compositions containing the same and a process for their production |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0882022A1 (en) |
JP (1) | JP2000501111A (en) |
AP (1) | AP844A (en) |
AU (1) | AU709239B2 (en) |
BR (1) | BR9707086A (en) |
CA (1) | CA2243121A1 (en) |
CZ (1) | CZ234498A3 (en) |
HU (1) | HUP9901024A2 (en) |
IL (1) | IL125479A0 (en) |
NO (1) | NO983435L (en) |
PL (1) | PL328223A1 (en) |
WO (1) | WO1997027180A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1019056A1 (en) * | 1997-05-17 | 2000-07-19 | Glaxo Group Limited | Antiviral combinations containing the carbocyclic nucleoside 1592u89 |
US6420401B1 (en) | 1997-08-22 | 2002-07-16 | Wichita State University | 1,2,5, thiadiazolidin-3-one 1,1-dioxide derivatives |
AU2012199A (en) * | 1997-12-24 | 1999-07-19 | Vertex Pharmaceuticals Incorporated | Prodrugs of aspartyl protease inhibitors |
US6337340B1 (en) * | 1998-08-14 | 2002-01-08 | Gpi Nil Holdings, Inc. | Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders |
EP1131306A2 (en) * | 1998-11-18 | 2001-09-12 | Du Pont Pharmaceuticals Company | Isoxazoline fibrinogen receptor antagonists |
DE10047110A1 (en) * | 2000-09-22 | 2002-04-18 | Bayer Ag | Optically active 2,5-bisaryl-DELTA · 1 · -pyrrolines |
AU2004243511A1 (en) | 2003-05-30 | 2004-12-09 | Neuromed Technologies, Inc | 3-aminomethyl-pyrrolidines as N-type calcium channel blockers |
SI1699455T1 (en) * | 2003-12-15 | 2013-10-30 | Merck Sharp & Dohme Corp. | Heterocyclic aspartyl protease inhibitors |
JP2005232103A (en) * | 2004-02-20 | 2005-09-02 | Nagase & Co Ltd | Optically active vicinaldiamine and method for producing the same |
GB0412019D0 (en) * | 2004-05-28 | 2004-06-30 | Novartis Ag | Organic compounds |
US7388008B2 (en) | 2004-08-02 | 2008-06-17 | Ambrilia Biopharma Inc. | Lysine based compounds |
CA2606025A1 (en) * | 2005-04-27 | 2006-11-02 | Ambrilia Biopharma Inc. | Method for improving pharmacokinetics of protease inhibitors and protease inhibitor precursors |
JP2008543841A (en) * | 2005-06-14 | 2008-12-04 | シェーリング コーポレイション | Macrocyclic heterocyclic aspartyl protease inhibitors |
ES2452718T3 (en) | 2005-11-30 | 2014-04-02 | Taimed Biologics, Inc. | Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation |
AU2007260985A1 (en) | 2006-06-20 | 2007-12-27 | Wyeth | Imidazolidinone Kv1.5 potassium channel inhibitors |
EP2064177B1 (en) | 2006-09-21 | 2017-04-05 | TaiMed Biologics, Inc. | Protease inhibitors |
EP2726108B1 (en) | 2011-06-29 | 2018-01-10 | The Trustees of Columbia University in the City of New York | Inhibitor of neuronal connectivity linked to schizophrenia susceptibility and cognitive dysfunction |
CN103626713B (en) * | 2012-08-29 | 2017-07-04 | 中国科学院上海药物研究所 | Ketone (thioketones) the class compound of nitrogen (oxygen) heterocycle pentane 2, its pharmaceutical composition, preparation method and purposes |
CN105111198B (en) * | 2015-08-05 | 2018-08-07 | 贵州大学 | Nitro isoxazole splices 2-Pyrrolidone class compound and preparation method and application |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5610294A (en) * | 1991-10-11 | 1997-03-11 | The Du Pont Merck Pharmaceutical Company | Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
ES2139195T3 (en) * | 1994-03-07 | 2000-02-01 | Vertex Pharma | SULFONAMID DERIVATIVES AS ASPARTIL-PROTEASE INHIBITORS. |
-
1997
- 1997-01-22 CZ CZ982344A patent/CZ234498A3/en unknown
- 1997-01-22 HU HU9901024A patent/HUP9901024A2/en unknown
- 1997-01-22 WO PCT/US1997/001610 patent/WO1997027180A1/en not_active Application Discontinuation
- 1997-01-22 JP JP9527124A patent/JP2000501111A/en active Pending
- 1997-01-22 PL PL97328223A patent/PL328223A1/en unknown
- 1997-01-22 IL IL12547997A patent/IL125479A0/en unknown
- 1997-01-22 BR BR9707086A patent/BR9707086A/en not_active Application Discontinuation
- 1997-01-22 AU AU17580/97A patent/AU709239B2/en not_active Ceased
- 1997-01-22 CA CA002243121A patent/CA2243121A1/en not_active Abandoned
- 1997-01-22 EP EP97904911A patent/EP0882022A1/en not_active Withdrawn
- 1997-01-24 AP APAP/P/1997/000961A patent/AP844A/en active
-
1998
- 1998-07-24 NO NO983435A patent/NO983435L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO983435D0 (en) | 1998-07-24 |
WO1997027180A1 (en) | 1997-07-31 |
CA2243121A1 (en) | 1997-07-31 |
CZ234498A3 (en) | 1998-10-14 |
HUP9901024A2 (en) | 1999-09-28 |
AU709239B2 (en) | 1999-08-26 |
AP9700961A0 (en) | 1997-04-30 |
JP2000501111A (en) | 2000-02-02 |
NO983435L (en) | 1998-09-21 |
PL328223A1 (en) | 1999-01-18 |
AU1758097A (en) | 1997-08-20 |
AP844A (en) | 2000-06-09 |
BR9707086A (en) | 1999-04-13 |
EP0882022A1 (en) | 1998-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL125479A0 (en) | Aspartyl protease inhibitors pharmaceutical compositions containing the same and a process for their production | |
PL326508A1 (en) | Protease inhibitors | |
HU9601508D0 (en) | Dp-iv-serine protease inhibitors | |
EP0580402A3 (en) | Aminediol protease inhibitors | |
IL112759A0 (en) | Novel cysteine protease inhibitors | |
EP0744948A4 (en) | Protease inhibitors | |
SI0874830T1 (en) | A metalloproteinase inhibitor, a pharmaceutical composition containing it and the pharmaceutical use and method useful for the preparation thereof | |
TJ339B (en) | A compound pharmaceutical composition and method for hiv protease inhibitors | |
PL322409A1 (en) | Reversible protease inhibitors | |
PL328307A1 (en) | Serinic protease inhibitors | |
IL120311A0 (en) | Serine protease inhibitors and pharmaceutical compositions containing them | |
HUP9900390A3 (en) | Serine protease inhibitors, and pharmaceutical compositions containing them | |
HUP9902256A3 (en) | Amidino protease inhibitors and pharmaceutical compositions containing them | |
ZA973062B (en) | New pharmaceutical formulation of a thrombin inhibitor for parenteral use. | |
HUP9802764A3 (en) | Guanidino protease inhibitors | |
ZA97613B (en) | Aspartyl protease inhibitors | |
EP0736302A3 (en) | Protease inhibitors, a DNA construct for the expression of a protease and a process for measuring proteases and/or protease inhibitors | |
ZA945234B (en) | Process for making HIV protease inhibitors | |
IL117437A0 (en) | Novel thrombin inhibitors | |
AU7133898A (en) | Nanosized aspartyl protease inhibitors | |
GB9603217D0 (en) | Serine protease inhibitors | |
AU5746296A (en) | Process for making hiv protease inhibitors | |
HUP9802645A3 (en) | New metalloproteinase inhibitors, process for producing them, and pharmaceutical compositions containing them | |
IL124534A0 (en) | Quinoxalinedione derivatives pharmaceutical compositions containing the same and a process for the production thereof | |
AU2377392A (en) | A method for the identification of protease inhibitors |